Evolus (EOLS) Interest Expenses (2017 - 2026)
Evolus' (EOLS) quarterly Interest Expenses came in at $4.0 million in Q1 2026, down 9.97% YoY from $4.4 million in Q1 2025, and little changed on a QoQ basis from $4.0 million in Q4 2025.
Evolus (EOLS) Interest Expenses (2017 - 2026) Analysis & Trends
Evolus (EOLS) has 10 years of Interest Expenses data on file, last reported at $4.0 million in Q1 2026.
- Quarterly Interest Expenses fell 9.97% year-over-year to $4.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $16.5 million (down 10.77% YoY) and the FY2025 annual result came in at $19.7 million, down 84.23% from the prior year.
- Interest Expenses held at $4.0 million in Q1 2026, from $4.0 million in the prior quarter.
- In the past five years, Interest Expenses ranged from a high of $15.6 million in Q2 2022 to a low of $2.6 million in Q4 2022.
- A 5-year average of $5.9 million and a median of $4.4 million in 2025 frame the typical range for Interest Expenses.
- The widest YoY moves for Interest Expenses: up 335.33% in 2022, down 99.57% in 2022.
- Tracing EOLS's Interest Expenses over 5 years: stood at $2.6 million in 2022, then jumped by 54.88% to $4.1 million in 2023, then increased by 12.22% to $4.6 million in 2024, then dropped by 13.01% to $4.0 million in 2025, then declined by 0.08% to $4.0 million in 2026.
- The last three Interest Expenses figures came in at $4.0 million (Q1 2026), $4.0 million (Q4 2025), and $4.1 million (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Expense (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.94 Bn | 42.97 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.08 Bn | 39.43 Bn | 2.15 Bn | - |
| 3 | Zoetis | 31.54 Bn | 29.87 Bn | 1.05 Bn | - |
| 4 | Takeda Pharmaceutical | 28.60 Bn | 22.80 Bn | 5.10 Bn | -400.56 Mn |
| 5 | United Therapeutics | 22.12 Bn | 19.46 Bn | 683.80 Mn | 2.90 Mn |
| 6 | Viatris | 18.75 Bn | 17.86 Bn | 1.46 Bn | 120.70 Mn |
| 7 | Neurocrine Biosciences | 15.50 Bn | 15.11 Bn | 935.80 Mn | 2.90 Mn |
| 8 | Elanco Animal Health | 11.69 Bn | 11.16 Bn | 798.00 Mn | 59.00 Mn |
| 9 | Dr Reddys Laboratories | 10.13 Bn | 9.96 Bn | - | - |
| 10 | Evolus | 550.84 Mn | 505.67 Mn | 57.18 Mn | 4.17 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 9.63 Mn |
| Jun 30, 2026 | 9.63 Mn |
| Mar 31, 2026 | 3.98 Mn |
| Mar 31, 2026 | 3.98 Mn |
| Dec 31, 2025 | 3.98 Mn |
| Dec 31, 2025 | 3.98 Mn |
| Sep 30, 2025 | 4.09 Mn |
| Sep 30, 2025 | 4.09 Mn |
| Jun 30, 2025 | 12.03 Mn |
| Jun 30, 2025 | 12.03 Mn |
| Mar 31, 2025 | 4.42 Mn |
| Mar 31, 2025 | 4.42 Mn |
| Dec 31, 2024 | 4.57 Mn |
| Dec 31, 2024 | 4.57 Mn |
| Sep 30, 2024 | 4.76 Mn |
| Sep 30, 2024 | 4.76 Mn |
| Jun 30, 2024 | 4.70 Mn |
| Jun 30, 2024 | 4.70 Mn |
| Mar 31, 2024 | 4.70 Mn |
| Mar 31, 2024 | 4.70 Mn |